Analysts anticipate on more revenue Johnson & Johnson

Tomorrow the American Johnson & Johnson will present her results over the past quarter. For this year most of the analyst expect a total sales of 72,14 billion dollars. This is slightly more than the revenue over 2015 of 70,07 billion dollars.

Historical revenues and results Johnson & Johnson plus taxations 2016

Johnson johnson health care company 2016

For 2016 the analysts expect a record net profit of 18,58 billion dollars. For this year most of the analysts expect a profit per share of 6,69 dollars. Based on this the price/earnings-ratio equals 17,57.

Per share a dividend of 3,14 dollars is expected. The dividend return consequently equals 2,67 percent. On average the health care company yields a rather limited dividend yield of around a rather limited percent.

Most recent target prices around 116 dollars

Johnson & Johnson is being covered by 9 analysts (only based on fundamental analysis). The average target price for the stock is at 115,78 dollars. This is around 2 percent less than the current stock price of 117,56 dollars. The 3 most recent recommendations for American were provided by Jefferies & Co. (hold, 115,00 dollars), Goldman Sachs (hold, 121,00 dollars) and Credit Suisse (hold, 112,00 dollars).

Based on the number of outstanding shares Johnson & Johnson 's market capitalization equals 323,9 billion dollars.

Friday the stock closed at 117,56 dollars. News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.